Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksASH.L Regulatory News (ASH)

  • There is currently no data for ASH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission Application Announcement

10 Feb 2016 07:00

RNS Number : 5304O
Ashley House PLC
10 February 2016
 

10 February 2016

Ashley House plc

("Ashley House" or the "Company")

Admission Application Announcement

The Company announces that, with effect from 8:00 a.m. today, the Company's ordinary shares will commence trading on the ISDX Growth Market under the ticker ASH.

Ashley House will be quoted on the Social Impact segment of the ISDX Growth Market and will remain listed on AIM following admission to ISDX.

 

Ends

Enquiries:

 

Ashley House plc 01628 600 340

Antony Walters

Jonathan Holmes

 

WH Ireland Limited 0207 220 1666

(Nominated Adviser, Corporate Adviser and broker to Ashley House plc)

Adrian Hadden

Mark Leonard

 

The following information is provided pursuant to the ISDX Growth Market Rules for Issuers:

Company Information

The Company is a leading extra care housing and health property partner working with providers and commissioners in the public, private & community sectors, and which is admitted to trading on AIM. The Company has 25 years of providing innovative approaches in the resourcing, funding, design and development of flexible and efficient social and community health, care and supported living environments.

Details of Directors

The full names of the Directors of the Company and positions are as follows:

Antony Walters, Chief Executive

Antony has a BA in accounting and qualified as a chartered accountant in 1992. He gained an ExecutiveMBA by evening study from Warwick University in 2004. He joined Ashley House in 2010 as FinanceDirector having held various senior executive positions within the Lloyds Pharmacy group, includingleading the corporate acquisitions, property and development teams. Antony spent 15 months in a panEuropean strategic development role based in Germany for Lloyds' parent company Celesio AG.Immediately prior to Ashley House, Antony was managing director of Sapphire Primary CareDevelopments Limited which Ashley House acquired from Lloyds Pharmacy in 2009. Antony wasappointed Chief Executive in October 2014.

Christopher Lyons, Non-Executive Chairman

Christopher has extensive experience in strategic planning, corporate governance, bankingand housing finance. His career spans 35 years, first with Abbey National where he held a number of seniorexecutive positions of increasing importance. He has also led major infrastructure projects such as the branch development programme and creating Cahoot, the internet bank.He then joined the executive Board of Minster Trust Limited, a fully regulated banking institutionleading the development and launch of an affinity based internet banking proposition.Christopher has extensive Non-executive experience chairing amongst others, the Boardof London Strategic Housing and recently as deputy chairman of Network Housing Group wherehe also chaired the Audit and Risk Committee. He holds a Masters degree in Strategic FinancialManagement and is a visiting fellow at Kingston and Durham Business Schools. Christopher hasalso worked with the NHS Commissioning Board authorising the recently formed nationalnetwork of Commissioning Support Units (CSUs), specifically assessing and developing business strategiesand the subsequent appointment of their managing directors. He chaired the advisoryBoard for the NHS Yorkshire and Humberside CSU and is currently a member of the NHS Arden Greater East Midlands CSU Advisory Board.

Stephen Minion, Non-Executive Deputy Chairman

Stephen is a chartered engineer with a long career in design and development of commercial property.Following the award of his degree in engineering he joined the London Borough of Harrow where hegained chartered engineer status. He moved to George Wimpey & Co and learnt his main"stock in trade" as a property developer before starting his own company in 1978. In 1991 heco-founded Ashley House where his specialist knowledge is invaluable in the delivery of the Company'score product and the development of new services. Stephen chairs the Company's RemunerationCommittee and is a Board member of a number of associated companies. 

Jonathan Holmes, Commercial Director

Prior to joining Ashley House in 1998, Jonathan worked in sales and marketing with an emphasis on settingup new ventures. In the 1990s he worked in the City for Thomson Financial Services and latterly the capitalmarkets and Eurobond regulator ISMA. Jonathan leads the Ashley House teams that work with clientsand stakeholders to source, structure and develop our projects. Jonathan is a passionate advocate ofAshley House's ability to use its status as a profit making plc to create social value well in excess of itssize and has led Ashley House's involvement as a Founder Member of the Social Stock Exchange.

Andrew Willetts, Non-executive Director

Andrew has a BA in history from Keble College, Oxford and qualified as a chartered accountant withwhat is now PricewaterhouseCoopers in 1991. He has held senior financial roles in the retail andwholesale sectors, including Waterstones and Hagemeyer (now part of the Rexel group). He joinedLloyds Pharmacy in 2003, becoming finance director in 2007 and public sector and healthcareservices director in 2012, with responsibility for the delivery of pharmacy services and pharmaceuticalsupply into NHS hospitals and other public and private sector organisations. He had Lloyds PharmacyBoard responsibility for Sapphire Primary Care Developments until its sale to Ashley House.Andrew is Chairman of Ashley House's Audit & Risk Committee.

John Moy, Non-executive Director

John has advised and invested in fast-growing companies for over 20 years including a period sittingon the panel of Non-executive directors appointed by 3i plc to their investee companies.In his industrial career he was both a Chartered Engineer and Chartered Management Accountantand was Factory Manager and Financial Controller for Mars Limited and a UK and Northern EuropeFinance Director for Motorola Inc. He was the Finance Director of the successful managementbuy-in of RHP Bearings. John provides strategic financial management skills and experienceto the Board.

Sector Classification

Ashley House will be classified as a Health Care Equipment & Services company on ISDX.

Shareholder Information

Shareholder

Number of Shares

% Shareholding

Pershing Nominees

6,000,000

10.29

Admenta Ltd (Lloyds Pharmacy)

5,493,827

9.42

John Moy (Non-Executive Director)

4,500,000

7.72

Stephen Minion (Non-Executive Deputy Chairman)

4,062,825

6.97

James Moy

3,000,000

5.14

Mrs. G. Mosley (former director)

2,125,518

3.64

Jonathan Holmes (Commercial Director)

2,088,736

3.58

Total Significant Shareholders

27,270,906

46.76

 

The Company operates an equity-settled share option scheme under which it has granted share options to its executive directors and certain senior managers. The options granted are cancelled in the event of the option holder leaving the Company. The options held by directors are set out below:

Director

Exercise price

Number of options

Antony Walters

9.75p

2,200,000

Jonathan Holmes

9.75p

2,000,000

4,200,000

 

The options, which have an exercise price of 9.75p, will not become exercisable unless and until the Company's share price equals or exceeds 37p for a period of at least 90 consecutive workings days and upon exercise is at or above the 37p threshold.

The percentage of securities in public hands (as defined in the ISDX Growth Market Rules for Issuers) is 55.6%. The percentage of securities not in public hands is 44.4%. There are no restrictions on the transfer of Ashley House's securities.

Further Information

Ashley House was admitted to trading on AIM on 15 January 2007; a copy of the admission document dated 12 January 2007 is available on the Company's website, www.ashleyhouseplc.com.

The Company will remain admitted to trading on AIM following admission to ISDX. Its ordinary shares are eligible for CREST settlement. The Company is subject to the UK City Code on Takeovers and Mergers.

Antony Walters, Chief Executive, commented:

"Ashley House is a founder member of the Social Stock Exchange (SSX) and is delighted to take this step to dual list now that SSX has a formal segment on a market. This will operate alongside our existing listing on AIM. Ashley House is a leading extra care housing and health property partner. Through the new listing we look forward to our business being more visible to investors seeking shares in companies with strong social values."

 The directors of Ashley House plc accept responsibility for this announcement.

Registered Address of Applicant

Ashley House plc

Unit 1, Barnes Wallis Court

Wellington Road

Cressex Business Park

High Wycombe

HP12 3PS

Telephone +44 (0)1628 600 340

www.ashleyhouseplc.com

 

Corporate Adviser and Contact Details

WH Ireland Ltd

24 Martin Lane

London

Adrian Hadden / Mark Leonard

Telephone: +44 (0)20 7220 1666

 

- Ends -

For further information please contact: 

Ashley House plc +44 (0) 1628 600 340

Antony Walters

Jonathan Holmes

 

WH Ireland Limited (NOMAD & Broker) +44 (0) 207 220 1666

Adrian Hadden

Mark Leonard

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCTLMBTMBJMBLF
Date   Source Headline
11th Dec 20205:30 pmRNSAshley House
11th Dec 20207:00 amRNSReverse Takeover Update and Administration
26th Aug 20201:27 pmRNSProposed Company Voluntary Arrangement
24th Aug 20207:00 amRNSProposed CVA – second adjournment of meeting
18th Aug 20201:05 pmRNSProposed CVA – adjournment of meeting
30th Jul 202012:25 pmRNSProposed CVA and potential Reverse Takeover
7th May 20205:25 pmRNSSale of Interests in PHL and LIFT
30th Mar 20201:59 pmRNSAdministration of F1 Modular and General Update
6th Mar 20207:30 amRNSSuspension - Ashley House Plc
6th Mar 20207:00 amRNSFinancial Update & Suspension of Trading
2nd Mar 202011:53 amRNSHolding(s) in Company
27th Feb 20207:00 amRNSTrading update & Withdrawal from NEX
31st Jan 20207:00 amRNSTrading Update
30th Jan 20201:45 pmRNSHolding(s) in Company
11th Dec 201911:01 amRNSAppointment of Non-executive director
10th Dec 201911:29 amRNSResult of Annual General Meeting
10th Dec 20197:00 amRNSAnnual General Meeting and Trading update
14th Nov 20197:00 amRNSYear End Change, Trading Update and Interim Report
7th Nov 20195:04 pmRNSDirectors' & PDMRs' Dealings
1st Nov 201910:10 amRNSHolding(s) in Company
30th Oct 20197:00 amRNSHolding(s) in Company
24th Oct 20192:23 pmRNSHolding(s) in Company
23rd Oct 20194:29 pmRNSHolding(s) in Company
21st Oct 20197:00 amRNSSale of Interest in Morgan Ashley
2nd Sep 20197:00 amRNSTrading Update
6th Aug 20197:00 amRNSDirectorate Change
5th Aug 20197:00 amRNSDirector/PDMR Shareholding
1st Aug 20192:05 pmRNSSecond Price Monitoring Extn
1st Aug 20192:00 pmRNSPrice Monitoring Extension
1st Aug 20197:00 amRNSTrading Update
5th Jul 20197:00 amRNSTrading Update
28th Jun 201911:51 amRNSHolding(s) in Company
25th Jun 20197:00 amRNSTrading Update
9th May 201910:19 amRNSDirector/PDMR Shareholding
9th May 20197:00 amRNSSchemes Update
3rd May 20191:21 pmRNSDirector/PDMR Shareholding
18th Feb 201912:56 pmRNSHolding(s) in Company
15th Feb 20192:53 pmRNSHolding(s) in Company
15th Feb 20192:50 pmRNSHolding(s) in Company
14th Feb 20194:41 pmRNSSecond Price Monitoring Extn
14th Feb 20194:35 pmRNSPrice Monitoring Extension
1st Feb 20191:38 pmRNSDirectors' & PDMRs' Dealings
31st Jan 20197:00 amRNSInterim Report
28th Jan 20199:40 amRNSAdditional Directorships - Andrew Willetts
16th Jan 201912:50 pmRNSChange of Accounting Year End
1st Nov 20187:00 amRNSDirectors' & PDMRs' Dealings
12th Sep 20181:08 pmRNSResult of AGM
16th Aug 20187:00 amRNSPreliminary Results
9th Aug 20187:00 amRNSJohn Moy
1st Aug 201811:34 amRNSDirectors' & PDMRs' Dealings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.